Lyra Therapeutics, Inc.LYRANASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank17
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
Latest
$-60.26M
↓ 57% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-38.26M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $-60.26M | +7.6% |
| 2023 | $-65.25M | -21.0% |
| 2022 | $-53.92M | -26.5% |
| 2021 | $-42.61M | -92.7% |
| 2020 | $-22.11M | -34.1% |
| 2019 | $-16.49M | -129.8% |
| 2018 | $-7.18M | - |